Felix Ausbuettel, Harald Schuett, Hans-Helge Mueller, Georgios Chatzis, Sebastian Weyand, Julian Mueller, Carlo-Federico Fichera, Bernhard Schieffer, Ulrich Luesebrink, Christian Waechter
{"title":"首先是房颤?探讨高级别功能性二尖瓣反流和心房颤动的心律控制。","authors":"Felix Ausbuettel, Harald Schuett, Hans-Helge Mueller, Georgios Chatzis, Sebastian Weyand, Julian Mueller, Carlo-Federico Fichera, Bernhard Schieffer, Ulrich Luesebrink, Christian Waechter","doi":"10.1007/s00392-025-02656-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) and functional mitral regurgitation (FMR) frequently coexist, presenting significant challenges for therapeutic management. Current evidence offers limited direction on the prioritization of treatment for these conditions. This study aims to evaluate the impact of rhythm control on high-grade FMR and identify predictors of persistent high-grade FMR after AF treatment.</p><p><strong>Methods: </strong>This single-center study analyzed patients with newly diagnosed AF and concomitant high-grade FMR. Predictors of persistent high-grade FMR after rhythm control of AF were assessed by logistic regression.</p><p><strong>Results: </strong>Among 795 patients hospitalized with new-onset AF, 14% (111/795) were diagnosed with high-grade FMR. Rhythm control successfully restored sinus rhythm in 86.3% of cases. FMR severity improved in 58.8% of patients, effectively eliminating the need for further interventions in these cases. Independent baseline predictors of persistent high-grade FMR at follow-up included New York Heart Association (NYHA) class IV heart failure symptoms, mean pulmonary artery pressure (mPAP) > 20 mmHg, effective regurgitant orifice area (EROA) > 0.4 cm<sup>2</sup>, vena contracta > 8 mm, and left atrial volume index (LAVI) > 48 mL/m<sup>2</sup>.</p><p><strong>Conclusions: </strong>Rhythm control of AF significantly reduced the severity of FMR in most patients, eliminating the need for mitral valve (MV) intervention in these cases. The identified predictors of persistent high-grade FMR could contribute to refined risk assessment and assist in treatment decision-making, potentially supporting early referral for MV intervention in appropriate patients.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Atrial fibrillation first? Investigating rhythm control in de novo high-grade functional mitral regurgitation and atrial fibrillation.\",\"authors\":\"Felix Ausbuettel, Harald Schuett, Hans-Helge Mueller, Georgios Chatzis, Sebastian Weyand, Julian Mueller, Carlo-Federico Fichera, Bernhard Schieffer, Ulrich Luesebrink, Christian Waechter\",\"doi\":\"10.1007/s00392-025-02656-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Atrial fibrillation (AF) and functional mitral regurgitation (FMR) frequently coexist, presenting significant challenges for therapeutic management. Current evidence offers limited direction on the prioritization of treatment for these conditions. This study aims to evaluate the impact of rhythm control on high-grade FMR and identify predictors of persistent high-grade FMR after AF treatment.</p><p><strong>Methods: </strong>This single-center study analyzed patients with newly diagnosed AF and concomitant high-grade FMR. Predictors of persistent high-grade FMR after rhythm control of AF were assessed by logistic regression.</p><p><strong>Results: </strong>Among 795 patients hospitalized with new-onset AF, 14% (111/795) were diagnosed with high-grade FMR. Rhythm control successfully restored sinus rhythm in 86.3% of cases. FMR severity improved in 58.8% of patients, effectively eliminating the need for further interventions in these cases. Independent baseline predictors of persistent high-grade FMR at follow-up included New York Heart Association (NYHA) class IV heart failure symptoms, mean pulmonary artery pressure (mPAP) > 20 mmHg, effective regurgitant orifice area (EROA) > 0.4 cm<sup>2</sup>, vena contracta > 8 mm, and left atrial volume index (LAVI) > 48 mL/m<sup>2</sup>.</p><p><strong>Conclusions: </strong>Rhythm control of AF significantly reduced the severity of FMR in most patients, eliminating the need for mitral valve (MV) intervention in these cases. The identified predictors of persistent high-grade FMR could contribute to refined risk assessment and assist in treatment decision-making, potentially supporting early referral for MV intervention in appropriate patients.</p>\",\"PeriodicalId\":10474,\"journal\":{\"name\":\"Clinical Research in Cardiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research in Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00392-025-02656-x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-025-02656-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Atrial fibrillation first? Investigating rhythm control in de novo high-grade functional mitral regurgitation and atrial fibrillation.
Background: Atrial fibrillation (AF) and functional mitral regurgitation (FMR) frequently coexist, presenting significant challenges for therapeutic management. Current evidence offers limited direction on the prioritization of treatment for these conditions. This study aims to evaluate the impact of rhythm control on high-grade FMR and identify predictors of persistent high-grade FMR after AF treatment.
Methods: This single-center study analyzed patients with newly diagnosed AF and concomitant high-grade FMR. Predictors of persistent high-grade FMR after rhythm control of AF were assessed by logistic regression.
Results: Among 795 patients hospitalized with new-onset AF, 14% (111/795) were diagnosed with high-grade FMR. Rhythm control successfully restored sinus rhythm in 86.3% of cases. FMR severity improved in 58.8% of patients, effectively eliminating the need for further interventions in these cases. Independent baseline predictors of persistent high-grade FMR at follow-up included New York Heart Association (NYHA) class IV heart failure symptoms, mean pulmonary artery pressure (mPAP) > 20 mmHg, effective regurgitant orifice area (EROA) > 0.4 cm2, vena contracta > 8 mm, and left atrial volume index (LAVI) > 48 mL/m2.
Conclusions: Rhythm control of AF significantly reduced the severity of FMR in most patients, eliminating the need for mitral valve (MV) intervention in these cases. The identified predictors of persistent high-grade FMR could contribute to refined risk assessment and assist in treatment decision-making, potentially supporting early referral for MV intervention in appropriate patients.
期刊介绍:
Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery.
As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.